Drug-price Transparency for Consumers Act of 2023
Legislative Progress
Introduced
October 13, 2023
Latest Action
December 17, 2024
Primary Sponsor
Abigail Davis SpanbergerDemocratic(VA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
94pct
431d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2024 · fourth_quarter · Medicare/Medicaid
Issues related to prescription drug prices. S.150/H.R.9070 Affordable Prescriptions for Patients Act. S.935 Fair Accountability and Innovative Research Drug Pricing Act. S.1250/H.R.5958 Drug Price Transparency for Consumers Act.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Medicare/Medicaid
Prescription drug pricing issues. S. 150/H.R. 9070 - Affordable Prescriptions for Patients Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act. S. 1250/H.R. 5958 - Drug Price Transparency for Consumers Act.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Medicare/Medicaid
Prescription drug pricing issues. S. 150/H.R. 9070 - Affordable Prescriptions for Patients Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act. S. 1250/H.R. 5958 - Drug Price Transparency for Consumers Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Medicare/Medicaid
Issues related to prescription drug prices. S.150 Affordable Prescriptions for Patients Act. S.935 Fair Accountability and Innovative Research Drug Pricing Act. S.1250/H.R.5958 Drug Price Transparency for Consumers Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Medicare/Medicaid
Issues related to prescription drug prices. S.150 Affordable Prescriptions for Patients Act. S.935 Fair Accountability and Innovative Research Drug Pricing Act. S.1250/H.R.5958 Drug Price Transparency for Consumers Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Medicare/Medicaid
Prescription drug pricing issues. S. 150 - Affordable Prescriptions for Patients Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act. S. 1250/H.R. 5958 - Drug Price Transparency for Consumers Act.
Client expense: Not reported · Firm income: $50,000
2024 · first_quarter · Medicare/Medicaid
Issues related to prescription drug prices. S.150 Affordable Prescriptions for Patients Act. S.935 Fair Accountability and Innovative Research Drug Pricing Act. S.1250/H.R.5958 Drug Price Transparency for Consumers Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Medicare/Medicaid
Prescription drug pricing issues. S. 150 - Affordable Prescriptions for Patients Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act. S. 1250/H.R. 5958 - Drug Price Transparency for Consumers Act.
Client expense: Not reported · Firm income: $50,000
2023 · fourth_quarter · Medicare/Medicaid
H.R. 2474, Strengthening Medicare for Patients and Providers Act, provisions relating to Medicare Economic Index inflation updates H.R. 6371, Provider Reimbursement Stability Act of 2023, provisions relating to budget neutrality, MIPS, and G2211 code H.R. 1610, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions S. 799, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions H.R. 751, Fair Access In Residency (FAIR) Act, all provisions H.R. 4189, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023, all provisions S. 2016, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023, all provisions H.R. 2829, Chronic Care Management Improvement Act of 2023, all provisions H.R. 1770, Equitable Community Access to Pharmacist Services Act, all provisions S. 2477, Equitable Community Access to Pharmacist Services Act, all provisions H.R. 2713, Improving Care and Access to Nurses (I CAN) Act, all provisions S. 2418, Improving Care and Access to Nurses (I CAN) Act, all provisions H.R. 977, Patient Access to Higher Quality Health Care Act of 2023, all provisions S. 470, Patient Access to Higher Quality Health Care Act of 2023, all provisions H.R. 2377, Saving Access to Laboratory Services Act, all provisions S. 1000, Saving Access to Laboratory Services Act, all provisions H.R. 3432, Telemental Health Care Access Act of 2023, all provisions H.R. 2389, Resident Physician Shortage Reduction Act of 2023, all provisions S. 1302, Resident Physician Shortage Reduction Act of 2023, all provisions S. 712, Connected MOM Act, all provisions H.R. 4968, Getting Over Lengthy Delays in Care As Required by Doctors (GOLD CARD) Act of 2023, all provisions H.R. 2474, Strengthening Medicare for Patients and Providers Act, all provisions H.R. 6683, Preserving Seniors Access to Physicians Act of 2023, all provisions H.R. 1610, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions S. 799, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions H.R. 6445, Medicare Audiology Access Improvement Act of 2023, all provisions S. 2377, Medicare Audiology Access Improvement Act of 2023, all provisions H.R. 6545, Physician Fee Schedule Update and Improvements Act, all provisions H.R. 6369, To amend title XVIII of the Social Security Act to extend incentive payments for participation in eligible alternative payment models, all provisions H.R. 6364, Medicare Telehealth Privacy Act of 2023, all provisions H.R. 4822, Health Care Price Transparency Act of 2023, all provisions H.R. 4839, Hospital and ASC Price Transparency Act of 2023, all provisions H.R. 5378, Lower Costs, More Transparency Act, all provisions H.R. 5013, Value in Health Care Act of 2023, all provisions S. 3503, Value in Health Care Act of 2023, all provisions H.R. 6545, Physician Fee Schedule Update and Improvements Act, all provisions H.R. 6366, To amend title XVIII of the Social Security Act with respect to the work geographic index for physician payments under the Medicare program, and to revise the phase-in of clinical laboratory test payment changes under such program, all provisions S. 1491, Pharmacy and Medically Underserved Areas Enhancement Act, all provisions S. 669, Increasing Mental Health Options Act of 2023, all provisions H.R. 2583, Increasing Access to Quality Cardiac Rehabilitation Care Act of 2023, all provisions H.R. 5958, Drug-price Transparency for Consumers Act of 2023, all provisions H.R. 3074, Due Process Continuity of Care Act, all provisions S. 971, Due Process Continuity of Care Act, all provisions H.R. 1694, Emergency Care Improvement Act, all provisions H.R. 1745, Medicare Fraud Detection and Deterrence Act of 2023, all provisions H.R. 1746, Preventing Medicare Telefraud Act, all provisions H.R. 497, Freedom for Health Care Workers Act, all provisions H.R. 5506, Hospitals As Naloxone Distribution Sites (HANDS) Act, all provisions H.R. 5388, Supporting Innovation for Seniors Act, all provisions H.R. 8863, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023, provisions relating to eliminating 3.37 Medicare cuts S. 198, Rural Health Clinic Burden Reduction Act, all provisions H.R. 4882, Clinical Laboratory Price Transparency Act of 2023, provisions relating to Section 101 H.R. 6475, Health Disparity Zones Act of 2023, all provisions H.R. 6230, Doctor Knows Best Act of 2023, all provisions S. 127, Pharmacy Benefit Manager Transparency Act of 2023, all provisions H.R. 3284, Providers and Payers COMPETE Act, all provisions H.R. 4828, Imaging Services Price Transparency Act of 2023, all provisions Improving Seniors Timely Access to Care Act of 2022 SURS Extension Act, provisions related to renewal of technical support for small practices in the Quality Payment Program Fewer Burdens for Better Care Act/drafts Medicare Student Education Authorization Act/drafts Medicare program: 21st Century Cures Act implementation Medicare program: No Surprises Act implementation Medicare program: Medicare Access and CHIP Reauthorization Act (MACRA)/physician burden Medicare program: MACRA/Broad reform Medicare program: Medicare Payment Advisory Commission (MedPAC)/Physician payment inflationary update Medicare program: Physician payment Medicare program: Provider Enrollment, Chain, and Ownership System (PECOS)/Revalidation Medicare program: Provider Relief Fund recoupment Medicare program: Open Payments Medicare program: Budget neutrality Medicare program: Merit-based Incentive Payment System (MIPS)/Cost performance category Medicare program: MIPS/quality/cost/promoting interoperability Medicare program: Quality/Diabetes measure Medicare program: Site neutral payment policies Medicare program: Physician-Owned Hospitals Medicare program: 3.37% CY 2024 Medicare cut Medicare program: Nursing home staff mandate Medicare program: Quality payment program/physician burdens Medicare program: Health IT/physician burdens Medicare program: EHR certification Medicare program: Miller-Meeks, Bera, Bucshon and Schrier letter/2024 Medicare cut Medicare program: Alternative payment models for specialists Medicare program: Medicare Advantage cuts/Advanced Rate Notice Medicare program: Scope of practice Medicare program: Prescription drug pricing and payment Medicare program: G2211 utilization Medicare program: Provider compliance and regulatory relief Medicaid program: Information blocking/reproductive health and penalties Medicare program: In-office pharmacies/Part B prescriptions/Stark Law Medicare program: Part B/geographic payment disparities Medicare and Medicaid programs: Data privacy Medicare and Medicaid programs: Lung cancer/low-dose computed tomography coverage expansion Medicare and Medicaid programs: Wheelchair repairs/barriers to timely access Medicare and Medicaid programs: Street medicine/place of service code Medicaid program: Medicaid unwinding/data collection Medicaid program: Maternal health
No bill number. Discussed the Medicare Drug Price Negotiation Program. H.R. 5958, the Drug-Price Transparency for Consumers (DTC) Act of 2023. H.R. 5429, the Medication Affordability and Patent Integrity Act. S. 2780, the Medication Affordability and Patent Integrity Act. S. 1339, the Pharmacy Benefit Manager Reform Act. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed the Inflation Reduction Act. S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act. S. 79, the Interagency Patent Coordination and Improvement Act of 2023. S. 113, the Prescription Pricing for the People Act of 2023. S. 142, Preserve Access to Affordable Generics and Biosimilars Act of 2023. S. 148, Stop STALLING Act. S. 150, the Affordable Prescriptions for Patients Act of 2023.
Client expense: $5,130,000 · Firm income: Not reported
2023 · fourth_quarter · Medicare/Medicaid
Issues related to prescription drug prices. S.150 Affordable Prescriptions for Patients Act. S.935 Fair Accountability and Innovative Research Drug Pricing Act. S.1250/H.R.5958 Drug Price Transparency for Consumers Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $5,740,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Treasury, Dept of
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office